243 related articles for article (PubMed ID: 2158515)
1. IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity.
Webb DS; Gerrard TL
J Immunol; 1990 May; 144(9):3643-8. PubMed ID: 2158515
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
3. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
van de Loosdrecht AA; Beelen RH; Ossenkoppele GJ; Broekhoven MG; Langenhuijsen MM
Exp Hematol; 1993 Mar; 21(3):461-8. PubMed ID: 8440344
[TBL] [Abstract][Full Text] [Related]
4. Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumor cells to monocyte-mediated lysis.
Webb DS; Mostowski HS; Gerrard TL
J Immunol; 1991 May; 146(10):3682-6. PubMed ID: 1673988
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes.
Feinman R; Henriksen-DeStefano D; Tsujimoto M; Vilcek J
J Immunol; 1987 Jan; 138(2):635-40. PubMed ID: 3098851
[TBL] [Abstract][Full Text] [Related]
6. [Induction of human monocyte-mediated tumor cell killing by alpha or beta interferon].
Utsugi T; Mutsuura S; Ogawara M; Shirahama T; Ishii K; Tsubura E; Sone S
Gan To Kagaku Ryoho; 1985 May; 12(5):1105-10. PubMed ID: 3994398
[TBL] [Abstract][Full Text] [Related]
7. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
[TBL] [Abstract][Full Text] [Related]
8. Lysis of tumor cells by human blood monocytes by a mechanism independent of activation of the oxidative burst.
Kleinerman ES; Ceccorulli LM; Bonvini E; Zicht R; Gallin JI
Cancer Res; 1985 May; 45(5):2058-64. PubMed ID: 2985242
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1.
Philip R; Epstein LB
Nature; 1986 Sep 4-10; 323(6083):86-9. PubMed ID: 3092113
[TBL] [Abstract][Full Text] [Related]
10. Protection of cultured human monocytes from lymphokine-activated killer-mediated lysis by IFN-gamma.
Blanchard DK; Djeu JY
J Immunol; 1988 Dec; 141(11):4067-73. PubMed ID: 2460557
[TBL] [Abstract][Full Text] [Related]
11. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
12. Cytolysis of tumor necrosis factor (TNF)-resistant tumor targets. Differential cytotoxicity of monocytes activated by the interferons, IL-2, and TNF.
Philip R
J Immunol; 1988 Feb; 140(4):1345-9. PubMed ID: 2449501
[TBL] [Abstract][Full Text] [Related]
13. Fc gamma RI and Fc gamma RII on monocytes and granulocytes are cytotoxic trigger molecules for tumor cells.
Graziano RF; Fanger MW
J Immunol; 1987 Nov; 139(10):3536-41. PubMed ID: 2960735
[TBL] [Abstract][Full Text] [Related]
14. Induction by interferon-alpha of tumoricidal activity of adherent mononuclear cells from human blood: monocytes as responder and effector cells.
Sone S; Utsugi T; Shirahama T; Ishii K; Mutsuura S; Ogawara M
J Biol Response Mod; 1985 Apr; 4(2):134-40. PubMed ID: 3998764
[TBL] [Abstract][Full Text] [Related]
15. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A
J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989
[TBL] [Abstract][Full Text] [Related]
16. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon.
Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J
J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232
[TBL] [Abstract][Full Text] [Related]
17. Human monocyte-mediated cytotoxicity: the use of Ig-bearing hybridomas as target cells to detect trigger molecules on the monocyte cell surface.
Graziano RF; Fanger MW
J Immunol; 1987 Feb; 138(3):945-50. PubMed ID: 2949010
[TBL] [Abstract][Full Text] [Related]
18. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
Nii A; Fidler IJ
Lymphokine Res; 1990; 9(2):113-24. PubMed ID: 2338840
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.
Ichinose Y; Bakouche O; Tsao JY; Fidler IJ
J Immunol; 1988 Jul; 141(2):512-8. PubMed ID: 3260254
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.
Kornbluth RS; Edgington TS
J Immunol; 1986 Oct; 137(8):2585-91. PubMed ID: 3760568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
